PropertyValue
?:abstract
  • The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1)
is ?:annotates of
?:creator
?:journal
  • Clinical_Medicine_Insights:_Circulatory,_Respiratory_and_Pulmonary_Medicine
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Asthma and COVID-19: What do we know now
?:type
?:who_covidence_id
  • #891524
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/7tsrl5w2>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/7tsrl5w2>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all